12 January 2021
The Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular disease is now calling for Expressions of Interest (EOI) for the first round of Research Projects funding.
We’re making available $18 million to support translational Research Projects that have the potential to transform diabetes and cardiovascular disease outcomes and reduce the burden of disease on patients, families and the community – with up to $6 million available in this first round.
Applications close at 16:00 AEDT on 22 February 2021.
We invite you to attend the TTRA Research Projects Information Session webinar on 19 January 2021 at 3:30-4:45pm AEDT, to learn more about this funding opportunity.
Dr Dan Grant, MTPConnect Managing Director & CEO will open the session to discuss the Research Projects opportunity.
Lauren Kelly, MTPConnect Senior Director TTRA program and Dr Mana Liao, MTPConnect Director TTRA program will then outline the priority areas, submission process and provide relevant information about preparing an application.
You will also hear from our TTRA program partners:
- ANDHealth’s Co-Founder & Chief Product Officer Grace Lethlean
- MDPP’s National Program Manager Olivia White and;
- UniQuest’s Senior Director QEDDI Dr Andrew Harvey
Register for the session today.